Amanat Holdings PJSC reported a 44% increase in profit for the first quarter of 2026, with a focus on strategic expansion and over AED 1 billion available for future investments. The company, which operates in the healthcare and education sectors across the GCC, saw a 24% rise in revenue and a 27% increase in EBITDA compared to Q1 2025. The healthcare segment, represented by Cambridge Health Group, experienced a 27% increase in revenue and a sixfold increase in profit, with significant growth in inpatient census and expansion plans underway. The education segment, Almasar Education, reported a 22% increase in revenue and a 29% increase in profit, with substantial growth in student enrollments and the development of new facilities. Amanat continues to focus on disciplined capital deployment to support scalable growth.

On 8 May 2026, Hamed Ahmed Ali, CEO of the Dubai Financial Market, received a notification regarding a meeting of the Board of Directors of Amanat Holdings PJSC. The meeting is scheduled for 14 May 2026, from 3:00 pm to 4:00 pm, both virtually and in person. The agenda includes the approval of the unaudited interim consolidated financial statements for the period ending 31 March 2026, the approval of a revised organizational structure and related management positions for Amanat Holdings, and other administrative matters that do not affect the share price. The notification was sent by Tessa Lee, with a copy to the UAE Capital Markets Authority.

On April 1, 2026, Amanat Holdings PJSC issued a Board of Directors resolution by circulation. The resolution includes the approval of funding up to SAR 65 million for newly issued shares by its majority-owned subsidiary, Cambridge Health Group, to expand its Jeddah hospital by approximately 70 beds, including outpatient and surgical services. Additionally, the resolution approves an amendment to the existing Liquidity Provider Agreement with Al-Ramz Capital LLC, allowing the provider to buy and sell ordinary shares of the company up to 5% of the share capital. Other administrative and routine matters that do not affect the share price were also addressed.

Amanat Holdings PJSC held its Annual General Assembly on March 31, 2026, where shareholders approved various agenda items, including the Board of Directors' and Auditor's reports, financial statements for 2025, and a record cash dividend of AED 175 million (7% per share). The meeting, with an 84% quorum, also approved the Board's remuneration, discharged the Board and auditors from liability for 2025, appointed an external auditor for 2026, and authorized Board members to engage in competing businesses under certain conditions. Additionally, the appointment of Mr. John Ireland to the Board was ratified. Chairman Dr. Ali Saeed bin Harmal Aldhaheri and CEO John Ireland expressed gratitude for shareholder support and emphasized the company's focus on sustainable growth and shareholder returns. The resolutions will be submitted to regulatory authorities.

On March 27, 2026, a notification was sent to Mr. Hamed Ahmed Ali, the CEO of the Dubai Financial Market, regarding a resolution by circulation from the Board of Directors of Amanat Holdings PJSC. The resolution, scheduled for consideration on April 1, 2026, includes the following points: providing funding for expansion projects at the majority-owned subsidiary, Cambridge Health Group; amending the liquidity provider agreement with Al-Ramz Capital LLC, a related party transaction, to allow the provider to buy and sell ordinary shares of the company within legal limits; and addressing other administrative and routine matters that do not affect the share price. The notification was signed by Tessa Lee.

Cambridge Health Group, a subsidiary of Amanat Holdings PJSC, has completed the acquisition of the remaining minority interest in Sukoon International Holding Company, bringing its ownership to 100%. Amanat initially acquired a 33.25% stake in Sukoon in 2015, gradually increasing it to 90.50% by November 2025. The acquisition aligns with Cambridge Health Group's strategy to become a leading post-acute care provider, delivering significant financial growth in 2025. Cambridge Health Group operates six facilities in the UAE and Saudi Arabia, providing post-acute care, rehabilitation, and home healthcare services.

Cambridge Health Group has appointed Wael Abdallah as its Chief Executive Officer, effective immediately. Abdallah, who served as Interim CEO since February 2025 and was previously Chief Investment Officer, has been instrumental in the company's strategic development and operational performance. As CEO, he will focus on expanding the group's regional offerings, enhancing operational excellence, and maintaining high patient care standards. The appointment follows a period of strong growth for Cambridge Health Group, with significant financial performance improvements in 2025. The group plans to increase its operational capacity from 625 to approximately 725 beds in 2026 and aims to deliver more than 1,000 post-acute care beds in the future. It is also exploring expansion opportunities and plans to broaden its clinical services. Abdallah expressed his commitment to building on the company's strong foundations and delivering outstanding patient outcomes.

A proxy form is presented for shareholders of Amanat Holdings PJSC to appoint a representative to vote on their behalf at the General Assembly meeting scheduled for Tuesday, March 31, 2026, or any subsequent adjourned meeting. The form requires details such as the shareholder's or investor's number, contact information for both the shareholder and the proxyholder, and the date and signature. Additionally, it includes a section for the name and contact details of the financial broker or entity that verified the proxy.